These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16723985)

  • 1. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective.
    Zoccali C
    Kidney Int; 2006 Jul; 70(1):26-33. PubMed ID: 16723985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel cardiovascular risk factors in end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S77-80. PubMed ID: 14684678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
    De Vriese AS; Verbeke F; Schrijvers BF; Lameire NH
    Kidney Int; 2002 Apr; 61(4):1199-209. PubMed ID: 11918726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study.
    Henry RM; Kostense PJ; Bos G; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD
    Kidney Int; 2002 Oct; 62(4):1402-7. PubMed ID: 12234312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of vascular disease in renal failure.
    Ikizler TA
    Blood Purif; 2002; 20(1):6-10. PubMed ID: 11803153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study.
    Gayoso-Diz P; Otero-González A; Rodríguez-Álvarez MX; García F; González-Quintela A; Martin de Francisco AL
    Nefrologia; 2013; 33(2):223-30. PubMed ID: 23511758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
    Lorenzen J; Krämer R; Kliem V; Bode-Boeger SM; Veldink H; Haller H; Fliser D; Kielstein JT
    Eur J Clin Invest; 2010 Apr; 40(4):294-300. PubMed ID: 20486990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of cardiovascular risk factors in chronic renal disease.
    Coresh J; Longenecker JC; Miller ER; Young HJ; Klag MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S24-30. PubMed ID: 11443765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic renal disease as cardiovascular risk factor].
    Hermans MM; Kooman JP; Stehouwer CD
    Ned Tijdschr Geneeskd; 2008 Jul; 152(29):1614-8. PubMed ID: 18998268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
    Stam F; van Guldener C; Becker A; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
    J Am Soc Nephrol; 2006 Feb; 17(2):537-45. PubMed ID: 16382015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease epidemics--a gap in effectiveness: the distance between potential and actual treatment benefits.
    Zoccali C; Cambareri F
    J Nephrol; 2006; 19(2):131-4. PubMed ID: 16736409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?
    Zoccali C; Kielstein JT
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):314-20. PubMed ID: 16609301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorenal disease: a clinical intersection.
    Kalra V; Mahajan S; Agarwal SK; Tiwari SC
    Int Urol Nephrol; 2005; 37(1):175-84. PubMed ID: 16132783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease.
    Stenvinkel P
    J Intern Med; 2010 Nov; 268(5):456-67. PubMed ID: 20809922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic kidney disease: novelties and scope of follow-up by the primary care physician].
    Sánchez Hernández R
    Nefrologia; 2008; 28 Suppl 5():113-7. PubMed ID: 18847430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.
    Zoccali C
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S61-3. PubMed ID: 16565249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Modification of Diet in Renal Disease 4-calculated glomerular filtration rate is a better prognostic factor of cardiovascular events than classical cardiovascular risk factors in patients with peripheral arterial disease.
    Romero JM; Bover J; Fite J; Bellmunt S; Dilmé JF; Camacho M; Vila L; Escudero JR
    J Vasc Surg; 2012 Nov; 56(5):1324-30. PubMed ID: 22795519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.